CA Stock MarketDetailed Quotes

Rapid Dose Therapeutics Corp (DOSE)

Watchlist
  • 0.105
  • 0.0000.00%
15min DelayMarket Closed May 12 09:30 ET
14.16MMarket Cap-5.25P/E (TTM)

Rapid Dose Therapeutics Corp (DOSE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Nov 30, 2025
(Q2)Aug 31, 2025
(Q1)May 31, 2025
(FY)Feb 28, 2025
(Q4)Feb 28, 2025
(Q3)Nov 30, 2024
(Q2)Aug 31, 2024
(Q1)May 31, 2024
(FY)Feb 29, 2024
(Q4)Feb 29, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-35.16%-303.08K
-65.13%-431.5K
30.45%-432.84K
50.03%-1.15M
92.61%-95.36K
66.67%-224.23K
-42.62%-261.31K
-368.73%-622.31K
-165.65%-2.29M
-1,338.90%-1.29M
Net income from continuing operations
16.41%-1.14M
24.93%-825.47K
42.42%-723.68K
-25.49%-5.4M
18.12%-1.68M
-39.08%-1.36M
-50.50%-1.1M
-121.71%-1.26M
-13.03%-4.31M
-57.57%-2.05M
Operating gains losses
----
----
----
----
----
----
----
----
--558.81K
----
Depreciation and amortization
162.87%126.6K
169.24%135.2K
61.71%133.78K
-61.19%240.75K
-67.01%59.65K
-68.49%48.16K
-64.18%50.22K
-43.53%82.73K
-1.14%620.31K
-36.41%180.77K
Remuneration paid in stock
----
----
----
--0
----
----
--0
----
-120.85%-5.97K
----
Remuneration paid in stock
-82.85%63.85K
-69.94%72.72K
-67.91%136.93K
772.92%1.42M
131.34%375.35K
--372.31K
--241.94K
--426.7K
-77.05%162.25K
200.30%162.25K
Other non cashItems
78.23%630.76K
82.82%435.91K
-4.54%216.03K
478.54%1.08M
714.92%391.77K
288.85%353.91K
443.16%238.44K
1,552.68%226.3K
54.93%187.42K
-57.69%48.08K
Change In working capital
-83.76%52.56K
-126.11%-80.37K
-95.63%-197.97K
210.25%1.52M
574.79%859.71K
401.38%323.7K
-7.10%307.76K
-136.95%-101.2K
-66.58%488.68K
-124.69%-181.07K
-Change in receivables
2,882.75%427.04K
38,638.76%485.2K
704.44%101.9K
-23.73%-83.3K
12.13%-113.22K
-79.68%14.32K
97.46%-1.26K
-141.46%-16.86K
-418.48%-67.32K
-1,001.62%-128.84K
-Change in inventory
154.61%20.91K
-238.37%-50.83K
79.21%-4.1K
-1,010.20%-114.54K
-7,308.58%-132.71K
-2,303.34%-38.29K
-16.15%36.73K
43.30%-19.73K
-83.98%12.58K
-98.05%1.84K
-Change in prepaid assets
-125.19%-13.36K
152.69%22.96K
153.86%12.86K
212.63%72.7K
-29.47%39.34K
133.30%53.04K
-428.84%-43.57K
-192.88%-23.88K
-209.72%-64.54K
-23.19%55.78K
-Change in payables and accrued expense
-234.97%-397.67K
-265.29%-522.06K
-657.82%-308.63K
164.18%1.64M
1,070.73%1.07M
94.29%294.63K
-4.71%315.85K
-116.42%-40.73K
-52.71%621.26K
-119.59%-109.85K
-Change in other working capital
--15.64K
---15.64K
----
----
----
----
----
----
-32.39%-13.3K
--0
Cash from discontinued investing activities
Operating cash flow
-0.13%-266.75K
-0.27%-262.01K
30.11%-434.9K
50.03%-1.15M
100.36%4.64K
60.40%-266.4K
-42.62%-261.31K
-368.73%-622.31K
-165.65%-2.29M
-1,338.90%-1.29M
Investing cash flow
Cash flow from continuing investing activities
0
0
-899
-5.74K
-5.74K
0
0
0
0
Net PPE purchase and sale
--0
--0
---899
---5.74K
---5.74K
--0
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
---899
---5.74K
---5.74K
--0
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
29.21%303.41K
19.13%262.01K
-14.74%489.65K
-58.32%1.01M
-101.42%-18.28K
-63.04%234.82K
-51.54%219.93K
316.22%574.32K
183.52%2.43M
1,314.22%1.29M
Net issuance payments of debt
--106.83K
394.15%262.01K
484.30%112K
-130.99%-379.14K
-47.91%-250K
--0
-121.58%-89.07K
-121.12%-29.14K
170.84%1.22M
-3,027.09%-169.02K
Net common stock issuance
--0
--0
--0
15.45%1.39M
-97.89%25.43K
--474.97K
--309K
--580.53K
693.65%1.21M
1,968.77%1.21M
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0
----
----
----
Net other financing activities
181.86%196.59K
----
1,547.10%377.65K
----
----
-196.06%-240.14K
----
--22.93K
----
----
Cash from discontinued financing activities
Financing cash flow
29.21%303.41K
19.13%262.01K
-14.74%489.65K
-58.32%1.01M
-101.42%-18.28K
-63.04%234.82K
-37.84%219.93K
316.22%574.32K
183.52%2.43M
1,314.22%1.29M
Net cash flow
Beginning cash position
-88.04%8.57K
-35.88%72.5K
-87.14%20.72K
483.82%161.06K
-75.87%40.1K
-64.76%71.68K
244.65%113.06K
483.82%161.06K
-19.90%27.59K
530.26%166.18K
Current changes in cash
418.53%100.59K
-54.48%-63.93K
207.88%51.78K
-205.15%-140.34K
-278.48%-19.38K
15.21%-31.58K
-124.25%-41.38K
-1,019.84%-48K
1,906.36%133.47K
-525.33%-5.12K
Effect of exchange rate changes
----
----
----
----
----
----
----
----
--0
----
End cash Position
172.23%109.16K
-88.04%8.57K
-35.88%72.5K
-87.14%20.72K
-87.14%20.72K
-75.87%40.1K
-64.76%71.68K
244.65%113.06K
483.82%161.06K
483.82%161.06K
Free cash from
-0.13%-266.75K
-0.27%-262.01K
29.97%-435.8K
49.78%-1.15M
99.91%-1.1K
60.40%-266.4K
-42.62%-261.31K
-368.73%-622.31K
-165.65%-2.29M
-1,338.90%-1.29M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Nov 30, 2025(Q2)Aug 31, 2025(Q1)May 31, 2025(FY)Feb 28, 2025(Q4)Feb 28, 2025(Q3)Nov 30, 2024(Q2)Aug 31, 2024(Q1)May 31, 2024(FY)Feb 29, 2024(Q4)Feb 29, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -35.16%-303.08K-65.13%-431.5K30.45%-432.84K50.03%-1.15M92.61%-95.36K66.67%-224.23K-42.62%-261.31K-368.73%-622.31K-165.65%-2.29M-1,338.90%-1.29M
Net income from continuing operations 16.41%-1.14M24.93%-825.47K42.42%-723.68K-25.49%-5.4M18.12%-1.68M-39.08%-1.36M-50.50%-1.1M-121.71%-1.26M-13.03%-4.31M-57.57%-2.05M
Operating gains losses ----------------------------------558.81K----
Depreciation and amortization 162.87%126.6K169.24%135.2K61.71%133.78K-61.19%240.75K-67.01%59.65K-68.49%48.16K-64.18%50.22K-43.53%82.73K-1.14%620.31K-36.41%180.77K
Remuneration paid in stock --------------0----------0-----120.85%-5.97K----
Remuneration paid in stock -82.85%63.85K-69.94%72.72K-67.91%136.93K772.92%1.42M131.34%375.35K--372.31K--241.94K--426.7K-77.05%162.25K200.30%162.25K
Other non cashItems 78.23%630.76K82.82%435.91K-4.54%216.03K478.54%1.08M714.92%391.77K288.85%353.91K443.16%238.44K1,552.68%226.3K54.93%187.42K-57.69%48.08K
Change In working capital -83.76%52.56K-126.11%-80.37K-95.63%-197.97K210.25%1.52M574.79%859.71K401.38%323.7K-7.10%307.76K-136.95%-101.2K-66.58%488.68K-124.69%-181.07K
-Change in receivables 2,882.75%427.04K38,638.76%485.2K704.44%101.9K-23.73%-83.3K12.13%-113.22K-79.68%14.32K97.46%-1.26K-141.46%-16.86K-418.48%-67.32K-1,001.62%-128.84K
-Change in inventory 154.61%20.91K-238.37%-50.83K79.21%-4.1K-1,010.20%-114.54K-7,308.58%-132.71K-2,303.34%-38.29K-16.15%36.73K43.30%-19.73K-83.98%12.58K-98.05%1.84K
-Change in prepaid assets -125.19%-13.36K152.69%22.96K153.86%12.86K212.63%72.7K-29.47%39.34K133.30%53.04K-428.84%-43.57K-192.88%-23.88K-209.72%-64.54K-23.19%55.78K
-Change in payables and accrued expense -234.97%-397.67K-265.29%-522.06K-657.82%-308.63K164.18%1.64M1,070.73%1.07M94.29%294.63K-4.71%315.85K-116.42%-40.73K-52.71%621.26K-119.59%-109.85K
-Change in other working capital --15.64K---15.64K-------------------------32.39%-13.3K--0
Cash from discontinued investing activities
Operating cash flow -0.13%-266.75K-0.27%-262.01K30.11%-434.9K50.03%-1.15M100.36%4.64K60.40%-266.4K-42.62%-261.31K-368.73%-622.31K-165.65%-2.29M-1,338.90%-1.29M
Investing cash flow
Cash flow from continuing investing activities 00-899-5.74K-5.74K0000
Net PPE purchase and sale --0--0---899---5.74K---5.74K--0--0--0--0----
Cash from discontinued investing activities
Investing cash flow --0--0---899---5.74K---5.74K--0--0--0--0----
Financing cash flow
Cash flow from continuing financing activities 29.21%303.41K19.13%262.01K-14.74%489.65K-58.32%1.01M-101.42%-18.28K-63.04%234.82K-51.54%219.93K316.22%574.32K183.52%2.43M1,314.22%1.29M
Net issuance payments of debt --106.83K394.15%262.01K484.30%112K-130.99%-379.14K-47.91%-250K--0-121.58%-89.07K-121.12%-29.14K170.84%1.22M-3,027.09%-169.02K
Net common stock issuance --0--0--015.45%1.39M-97.89%25.43K--474.97K--309K--580.53K693.65%1.21M1,968.77%1.21M
Proceeds from stock option exercised by employees --------------------------0------------
Net other financing activities 181.86%196.59K----1,547.10%377.65K---------196.06%-240.14K------22.93K--------
Cash from discontinued financing activities
Financing cash flow 29.21%303.41K19.13%262.01K-14.74%489.65K-58.32%1.01M-101.42%-18.28K-63.04%234.82K-37.84%219.93K316.22%574.32K183.52%2.43M1,314.22%1.29M
Net cash flow
Beginning cash position -88.04%8.57K-35.88%72.5K-87.14%20.72K483.82%161.06K-75.87%40.1K-64.76%71.68K244.65%113.06K483.82%161.06K-19.90%27.59K530.26%166.18K
Current changes in cash 418.53%100.59K-54.48%-63.93K207.88%51.78K-205.15%-140.34K-278.48%-19.38K15.21%-31.58K-124.25%-41.38K-1,019.84%-48K1,906.36%133.47K-525.33%-5.12K
Effect of exchange rate changes ----------------------------------0----
End cash Position 172.23%109.16K-88.04%8.57K-35.88%72.5K-87.14%20.72K-87.14%20.72K-75.87%40.1K-64.76%71.68K244.65%113.06K483.82%161.06K483.82%161.06K
Free cash from -0.13%-266.75K-0.27%-262.01K29.97%-435.8K49.78%-1.15M99.91%-1.1K60.40%-266.4K-42.62%-261.31K-368.73%-622.31K-165.65%-2.29M-1,338.90%-1.29M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More